No Data
No Data
Yuanfei Pet (001222): Net profit increased 73% in 1Q24, focus on order repair to lead subsequent growth
The 2023 and 1Q24 results are in line with market expectations. The company announced 2023 and 1Q24 results. Revenue reached 99/250 million yuan respectively, an increase of 3.9%/30.7%, and net profit to mother of 1.3/
Yuanfei Pet (001222): Steady restoration of operations, gradual recovery in overseas markets can be expected
Core view: Yuanfei Pet publishes 23 annual reports and 24 quarterly reports. In '23, the company achieved revenue of 991 million yuan, a year-on-year increase of 3.94%, and net profit to mother of 126 million yuan, a year-on-year decrease of 20.45%, not deducted from the mother
Yuanfei Pet (001222.SZ) released 2023 annual results, with net profit of 126 million yuan, a year-on-year decrease of 20.45%
Yuanfei Pet (001222.SZ) released its 2023 annual report. During the reporting period, the company achieved an operating income of 9...
Yuanfei Pet (001222.SZ): Net profit of 365.3696 million yuan in the first quarter increased 72.51% year-on-year
Gelonghui, April 28, 丨 Yuanfei Pet (001222.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 246 million yuan, up 30.67% year on year; net profit attributable to shareholders of listed companies was 365.36,96 million yuan, up 72.51% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 334.209 million yuan, an increase of 59.66% year on year; basic earnings per share were 0.1914 yuan.
Yuanfei Pet (001222.SZ): There are currently no plans to develop in the direction of pet medicine
Gelonghui, April 26 | Yuanfei Pet (001222.SZ) said on the investor interactive platform that the company has focused on R&D, production and sales of pet products and pet food for many years. The main products include pet products such as pet traction equipment, pet injection toys, and pet food such as dog chewing gum. Regarding the company's performance, please pay attention to the 2023 annual report and the first quarter of 2024 report to be disclosed by the company on April 29, 2024. The company currently has no plans to develop in the direction of pet medicine.
Pingyang Shengxun, the shareholder of Yuanfei Pet (001222.SZ), reduced its holdings by 0.49%, and the reduction period expired
Zhitong Finance App News, Yuanfei Pet (001222.SZ) issued an announcement. Recently, the company received a “Notice Letter on the Expiration of the Stock Holdings Reduction Plan and the Results of the Shareholding Reduction” issued by shareholder Pingyang Shengxun. Up to now, shareholder Pingyang Shengxun's current share reduction plan has expired. This time, his holdings have been reduced by a total of 927,700 shares, or 0.49%.
No Data